Airfinity analysis on data from the Wegovy trial on cardiovascular outcomes reveals that even after a 65% rebate on the list price, it will cost $1.1m to prevent one heart attack, stroke or cardiovascular death.
Source: Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death | Airfinity